BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
14 results:

  • 1. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
    Lu K; Chiu KY
    Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer.
    Qiu H; Makarov V; Bolzenius JK; Halstead A; Parker Y; Wang A; Iyer GV; Wise H; Kim D; Thayaparan V; Lindner DJ; Haber GP; Ting AH; Ren B; Chan TA; Arora V; Solit DB; Lee BH
    Cancer Res; 2023 Mar; 83(6):814-829. PubMed ID: 36638328
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.
    Yang W; Chen H; Ma L; Dong J; Wei M; Xue X; Li Y; Jin Z; Xu W; Ji Z
    Aging (Albany NY); 2022 Dec; 14(24):10107-10124. PubMed ID: 36585925
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Systematic Pan-Cancer Analysis and Experimental Verification Identify foxa1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer.
    Wang K; Guan C; Yu J; Chen X; Shang X; Mei S; Feng X; Zheng L
    Dis Markers; 2022; 2022():9328972. PubMed ID: 36393971
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression.
    Liu W; Ren D; Xiong W; Jin X; Zhu L
    J Exp Clin Cancer Res; 2022 Jan; 41(1):38. PubMed ID: 35081978
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects.
    Osako T; Lee H; Turashvili G; Chiu D; McKinney S; Joosten SEP; Wilkinson D; Nielsen TO; Zwart W; Emerman JT; Eaves CJ; Caldas C; Aparicio S
    Nat Cancer; 2020 May; 1(5):518-532. PubMed ID: 35121983
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
    Guo Y; Yuan X; Li K; Dai M; Zhang L; Wu Y; Sun C; Chen Y; Cheng G; Liu C; Strååt K; Kong F; Zhao S; Bjorkhölm M; Xu D
    Cell Death Differ; 2020 Jun; 27(6):1862-1877. PubMed ID: 31802036
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting foxa1.
    Tong Z; Meng X; Wang J; Wang L
    Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Altered Expression of the Transcription Factor Forkhead Box A1 (foxa1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract.
    Raman JD; Warrick JI; Caruso C; Yang Z; Shuman L; Bruggeman RD; Shariat S; Karam JA; Wood C; Weizer AZ; Remzi M; Haitel A; Bensalah K; Rioux-Leclerq N; Bolenz C; Roscigno M; Krabbe LM; Kapur P; Lotan Y; Margulis V; DeGraff DJ
    Urology; 2016 Aug; 94():314.e1-7. PubMed ID: 27215483
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.
    Neely BA; Wilkins CE; Marlow LA; Malyarenko D; Kim Y; Ignatchenko A; Sasinowska H; Sasinowski M; Nyalwidhe JO; Kislinger T; Copland JA; Drake RR
    PLoS One; 2016; 11(4):e0154074. PubMed ID: 27128972
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of foxa1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
    Yao L; Shen H; Laird PW; Farnham PJ; Berman BP
    Genome Biol; 2015 May; 16(1):105. PubMed ID: 25994056
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.
    DeGraff DJ; Cates JM; Mauney JR; Clark PE; Matusik RJ; Adam RM
    Urol Oncol; 2013 Aug; 31(6):802-11. PubMed ID: 21924649
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.
    Chiaverotti T; Couto SS; Donjacour A; Mao JH; Nagase H; Cardiff RD; Cunha GR; Balmain A
    Am J Pathol; 2008 Jan; 172(1):236-46. PubMed ID: 18156212
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.